CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

UGT1A1 *28 — belinostat toxicity

Gene: UGT1A1 · Type: variant

Indications: Peripheral T-cell lymphoma

SensitivityResistanceCIViC Context

FDA Resistance Assertions

DrugIndicationRecommendationFDA SourceLink
BelinostatPeripheral T-cell lymphomaNOT RECOMMENDED
FDA Label
Label